Loading...
Reduced risk of all-cancer and solid cancer in Taiwanese patients with rheumatoid arthritis treated with etanercept, a TNF-α inhibitor
Biologics has been widely used in the treatment of rheumatoid arthritis. We aimed to determine whether etanercept, a TNF-α inhibitor (TNFi) that is used to treat patients with rheumatoid arthritis (RA), affects cancer risk. This retrospective matched cohort study used data in the Registry of Catastr...
Saved in:
| Published in: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Wolters Kluwer Health
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5319502/ https://ncbi.nlm.nih.gov/pubmed/28207513 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000006055 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|